Evidence map›Paper›PMID 33503999›Full record

ArticleInternational journal of molecular sciences2021

Identification of Novel Substrates for cGMP Dependent Protein Kinase (PKG) through Kinase Activity Profiling to Understand Its Putative Role in Inherited Retinal Degeneration.

Akanksha Roy, John Groten, Valeria Marigo, Tushar Tomar, Riet Hilhorst

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Integrative Kinase Activity Profiling and Phosphoproteomics ofInternational journal of molecular sciences · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Redefining the role of CaCell death & disease · 2022
    Article
  8. Frontiers in neuroscience · 2022
    Review
  9. Review
  10. New In Vitro Cellular Model for Molecular Studies of Retinitis Pigmentosa.International journal of molecular sciences · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Akanksha RoyDivision of Toxicology, Wageningen University and Research, Stippeneng 4, 6708 WE Wageningen, The Netherlands.ORCID 0000-0002-9683-4020
John GrotenDivision of Toxicology, Wageningen University and Research, Stippeneng 4, 6708 WE Wageningen, The Netherlands.
Valeria MarigoDepartment of Life Sciences, University of Modena and Reggio Emilia, via Campi, 287, 41125 Modena, Italy.
Tushar TomarPamGene International B.V., P.O. Box 1345, 5200 BJ 's-Hertogenbosch, The Netherlands.ORCID 0000-0002-3344-7605
Riet HilhorstPamGene International B.V., P.O. Box 1345, 5200 BJ 's-Hertogenbosch, The Netherlands.
PamGene (Netherlands) · NLUniversity of Modena and Reggio Emilia · IT

Funding

H2020 Marie Skłodowska-Curie Actions . 765441
6 · The paper itself

Abstract

Inherited retinal degenerative diseases (IRDs), which ultimately lead to photoreceptor cell death, are characterized by high genetic heterogeneity. Many IRD-associated genetic defects affect 3',5'-cyclic guanosine monophosphate (cGMP) levels. cGMP-dependent protein kinases (PKGI and PKGII) have emerged as novel targets, and their inhibition has shown functional protection in IRDs. The development of such novel neuroprotective compounds warrants a better understanding of the pathways downstream of PKGs that lead to photoreceptor degeneration. Here, we used human recombinant PKGs in combination with PKG activity modulators (cGMP, 3',5'-cyclic adenosine monophosphate (cAMP), PKG activator, and PKG inhibitors) on a multiplex peptide microarray to identify substrates for PKGI and PKGII. In addition, we applied this technology in combination with PKG modulators to monitor kinase activity in a complex cell system, i.e. the retinal cell line 661W, which is used as a model system for IRDs. The high-throughput method allowed quick identification of

Indexed as

Disease SusceptibilityAmino Acid SequenceBiomarkersCarrier ProteinsCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic GMPEnzyme ActivationGenetic Predisposition to DiseaseHumansKineticsProtein BindingRetinal DegenerationSubstrate SpecificityBiomarkersCarrier ProteinsCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic GMP661WcAMPcGMPpeptide microarrayPKAPKGretinal degenerationsubstrate identification

Identifiers

PMID33503999
PMCPMC7865299
OpenAlexW3124561197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.